Protara therapeutics, inc. reports inducement grants under nasdaq listing rule 5635(c)(4)

New york, may 01, 2025 (globe newswire) -- protara therapeutics, inc. (nasdaq: tara) (“protara” or the “company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent grants of inducement non-qualified stock options and restricted stock units (rsus) to six newly-hired employees.

NDAQ Ratings Summary

NDAQ Quant Ranking